Yasuhiro Masubuchi

1.1k total citations
29 papers, 902 citations indexed

About

Yasuhiro Masubuchi is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Yasuhiro Masubuchi has authored 29 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yasuhiro Masubuchi's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). Yasuhiro Masubuchi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). Yasuhiro Masubuchi collaborates with scholars based in Japan, United States and Czechia. Yasuhiro Masubuchi's co-authors include Toshiharu Horie, Timothy P. Reilly, Mohammed Bourdi, John W. George, Lance R. Pohl, Hamid Amouzadeh, Jackie L. Martin, Shizuo Narimatsu, Yasuko Watanabe and Mary L. Graf and has published in prestigious journals such as Hepatology, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Yasuhiro Masubuchi

29 papers receiving 878 citations

Peers

Yasuhiro Masubuchi
Sheryl G. Wood United States
Mary K. Bruno United States
Lynda Letzig United States
Vsevolod E. Kostrubsky United States
Sandra McCullough United States
Anima Ghosal United States
Veronica F. Price United States
Josef Gut Switzerland
Tamara R. Knight United States
Camilla Stephens Spain
Sheryl G. Wood United States
Yasuhiro Masubuchi
Citations per year, relative to Yasuhiro Masubuchi Yasuhiro Masubuchi (= 1×) peers Sheryl G. Wood

Countries citing papers authored by Yasuhiro Masubuchi

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Masubuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Masubuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Masubuchi more than expected).

Fields of papers citing papers by Yasuhiro Masubuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Masubuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Masubuchi. The network helps show where Yasuhiro Masubuchi may publish in the future.

Co-authorship network of co-authors of Yasuhiro Masubuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Masubuchi. A scholar is included among the top collaborators of Yasuhiro Masubuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Masubuchi. Yasuhiro Masubuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masubuchi, Yasuhiro, et al.. (2023). Efficacy of oltipraz in preventing acetaminophen-induced liver injury in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(2). 923–930. 2 indexed citations
2.
Masubuchi, Yasuhiro, et al.. (2022). Protection of mice against carbon tetrachloride-induced acute liver injury by endogenous and exogenous estrogens. Drug Metabolism and Pharmacokinetics. 46. 100460–100460. 4 indexed citations
3.
Masubuchi, Yasuhiro, et al.. (2013). Time‐dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor. Biopharmaceutics & Drug Disposition. 34(8). 423–430. 20 indexed citations
4.
Masubuchi, Yasuhiro, et al.. (2011). Sex difference in susceptibility to acetaminophen hepatotoxicity is reversed by buthionine sulfoximine. Toxicology. 287(1-3). 54–60. 53 indexed citations
5.
Masubuchi, Yasuhiro, et al.. (2011). Protective Effects of Exogenous Glutathione and Related Thiol Compounds against Drug-Induced Liver Injury. Biological and Pharmaceutical Bulletin. 34(3). 366–370. 24 indexed citations
6.
Masubuchi, Yasuhiro, et al.. (2008). Th1/Th2 cytokine balance as a determinant of acetaminophen-induced liver injury. Chemico-Biological Interactions. 179(2-3). 273–279. 59 indexed citations
7.
Tachibana, Masaya, Makoto Tanaka, Yasuhiro Masubuchi, & Toshiharu Horie. (2005). ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(6). 803–811. 33 indexed citations
8.
Masubuchi, Yasuhiro, Mohammed Bourdi, Timothy P. Reilly, et al.. (2003). Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochemical and Biophysical Research Communications. 304(1). 207–212. 115 indexed citations
9.
Bourdi, Mohammed, Yasuhiro Masubuchi, Timothy P. Reilly, et al.. (2002). Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase. Hepatology. 35(2). 289–298. 244 indexed citations
10.
Masubuchi, Yasuhiro, et al.. (2002). Plasma Retinol Binding Protein for Monitoring the Acetaminophen-induced Hepatotoxicity. Drug Metabolism and Pharmacokinetics. 17(6). 540–545. 1 indexed citations
11.
Masubuchi, Yasuhiro, et al.. (2002). Evaluation of drug-induced hepatotoxicity by plasma retinol binding protein.. PubMed. 16(1). 61–5. 5 indexed citations
12.
13.
Horie, Toshiharu, et al.. (1998). Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sciences. 62(15). 1333–1338. 30 indexed citations
14.
Masubuchi, Yasuhiro, et al.. (1997). Evaluation of damaged small intestine of mouse following methotrexate administration. Cancer Chemotherapy and Pharmacology. 41(2). 98–102. 32 indexed citations
15.
Narimatsu, Shizuo, Yasuhiro Masubuchi, Toshiharu Horie, et al.. (1996). Stereoselectivity in Bunitrolol 4-Hydroxylation in Liver Microsomes from Marmosets and Japanese Monkeys.. Biological and Pharmaceutical Bulletin. 19(11). 1429–1433. 15 indexed citations
16.
Kariya, Satoru, et al.. (1995). Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine. Biochemical Pharmacology. 50(10). 1645–1650. 16 indexed citations
17.
Narimatsu, Shizuo, et al.. (1995). Cytochrome P450 Isozymes Involved in Aromatic Hydroxylation and Side-Chain N-Desisopropylation of Alprenolol in Rat Liver Microsomes.. Biological and Pharmaceutical Bulletin. 18(8). 1060–1065. 8 indexed citations
18.
Narimatsu, Shizuo, Toshiyuki Watanabe, Yasuhiro Masubuchi, et al.. (1995). Characterization of a Chemically Reactive Propranolol Metabolite That Binds to Microsomal Proteins of Rat Liver. Chemical Research in Toxicology. 8(5). 721–728. 17 indexed citations
19.
Obara, Sakaé, et al.. (1992). Induction of propranolol metabolism by the azo dye sudan III in rats. Biochemical Pharmacology. 43(11). 2489–2492. 14 indexed citations
20.
Fujita, Shoichi, et al.. (1990). MECHANISM OF ALTERATIONS OF NON-LINEARITY IN HEPATIC FIRST-PASS METABOLISM OF PROPRANOLOL : ALTERATIONS IN THE RELATIVE ABUNDANCE OF CYTOCHROME P-450 ISOZYMES IN THE LIVER MICROSOMES IN RELATION TO THE ORGAN-LEVEL METABOLIC ACTIVITIES. Journal of Pharmacobio-Dynamics. 13(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheryl G. Wood Breakdown of academic impact, for papers by Mary K. Bruno Breakdown of academic impact, for papers by Lynda Letzig Breakdown of academic impact, for papers by Vsevolod E. Kostrubsky Breakdown of academic impact, for papers by Sandra McCullough Breakdown of academic impact, for papers by Anima Ghosal Breakdown of academic impact, for papers by Veronica F. Price Breakdown of academic impact, for papers by Josef Gut Breakdown of academic impact, for papers by Tamara R. Knight Breakdown of academic impact, for papers by Camilla Stephens
Rankless by CCL
2026